Genomics Market in US 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	151 Pages	TechNavio	September, 2024	INF19287909

Best Price Guarantee
Price	from $2,500
Length	151 Pages
Publisher	TechNavio
Published Date	September, 2024
SKU	INF19287909

Genomics Market In US 2024-2028

The genomics market in US is forecasted to grow by USD 6966.8 mn during 2023-2028, accelerating at a CAGR of 12.1% during the forecast period. The report on the genomics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reduction in cost of genetic sequencing, increasing demand for creating and upgrading genome databases, and growing demand for personalized medicine.

Technavio's genomics market in US is segmented as below:

By Application
Diagnostics
Drug discovery
Others
By End-user
Hospitals and clinics
Academic and research institutes
Pharmaceutical and biotechnology companies
Others
By Solution
Products
Services
By Geographical Landscape
North America

This study identifies the growing adoption of single cell-based genomics analysis as one of the prime reasons driving the genomics market in US growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in US covers the following areas:

Genomics Market in US sizing
Genomics Market in US forecast
Genomics Market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in US vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Perkin Elmer Inc., Personalis Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. Also, the genomics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Solution; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US: Year-over-year growth 2023-2028 (%); Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Genomics Market in US 2018 - 2022; Historic Market Size - Data Table on Genomics Market in US 2018 - 2022 ($ million); 4.2 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Solution segment analysis 2018 - 2022; Historic Market Size - Solution Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 6.3 Diagnostics - Market size and forecast 2023-2028; Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); 6.4 Drug discovery - Market size and forecast 2023-2028; Chart on Drug discovery - Market size and forecast 2023-2028 ($ million); Data Table on Drug discovery - Market size and forecast 2023-2028 ($ million); Chart on Drug discovery - Year-over-year growth 2023-2028 (%); Data Table on Drug discovery - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 7.3 Hospitals and clinics - Market size and forecast 2023-2028; Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%); 7.4 Academics and research institutes - Market size and forecast 2023-2028; Chart on Academics and research institutes - Market size and forecast 2023-2028 ($ million); Data Table on Academics and research institutes - Market size and forecast 2023-2028 ($ million); Chart on Academics and research institutes - Year-over-year growth 2023-2028 (%); Data Table on Academics and research institutes - Year-over-year growth 2023-2028 (%); 7.5 Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028; Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million); Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million); Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%); Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
8 Market Segmentation by Solution: 8.1 Market segments; Chart on Solution - Market share 2023-2028 (%); Data Table on Solution - Market share 2023-2028 (%); 8.2 Comparison by Solution; Chart on Comparison by Solution; Data Table on Comparison by Solution; 8.3 Products - Market size and forecast 2023-2028; Chart on Products - Market size and forecast 2023-2028 ($ million); Data Table on Products - Market size and forecast 2023-2028 ($ million); Chart on Products - Year-over-year growth 2023-2028 (%); Data Table on Products - Year-over-year growth 2023-2028 (%); 8.4 Services - Market size and forecast 2023-2028; Chart on Services - Market size and forecast 2023-2028 ($ million); Data Table on Services - Market size and forecast 2023-2028 ($ million); Chart on Services - Year-over-year growth 2023-2028 (%); Data Table on Services - Year-over-year growth 2023-2028 (%); 8.5 Market opportunity by Solution; Market opportunity by Solution ($ million); Data Table on Market opportunity by Solution ($ million)
9 Customer Landscape: 9.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; 12.4 BGI Genomics Co. Ltd.; BGI Genomics Co. Ltd. - Overview; BGI Genomics Co. Ltd. - Product / Service; BGI Genomics Co. Ltd. - Key offerings; 12.5 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; 12.6 Color Health Inc.; Color Health Inc. - Overview; Color Health Inc. - Product / Service; Color Health Inc. - Key offerings; 12.7 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; 12.8 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.9 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.10 LetsGetChecked; LetsGetChecked - Overview; LetsGetChecked - Product / Service; LetsGetChecked - Key offerings; 12.11 Myriad Genetics Inc.; Myriad Genetics Inc. - Overview; Myriad Genetics Inc. - Product / Service; Myriad Genetics Inc. - Key news; Myriad Genetics Inc. - Key offerings; 12.12 Oxford Nanopore Technologies plc; Oxford Nanopore Technologies plc - Overview; Oxford Nanopore Technologies plc - Product / Service; Oxford Nanopore Technologies plc - Key offerings; 12.13 Pacific Biosciences of California Inc.; Pacific Biosciences of California Inc. - Overview; Pacific Biosciences of California Inc. - Product / Service; Pacific Biosciences of California Inc. - Key news; Pacific Biosciences of California Inc. - Key offerings; 12.14 Perkin Elmer Inc.; Perkin Elmer Inc. - Overview; Perkin Elmer Inc. - Business segments; Perkin Elmer Inc. - Key news; Perkin Elmer Inc. - Key offerings; Perkin Elmer Inc. - Segment focus; 12.15 QIAGEN N.V.; QIAGEN N.V. - Overview; QIAGEN N.V. - Product / Service; QIAGEN N.V. - Key news; QIAGEN N.V. - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; 12.17 Twist Bioscience Corp.; Twist Bioscience Corp. - Overview; Twist Bioscience Corp. - Product / Service; Twist Bioscience Corp. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Application; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Solution; Exhibits7: Executive Summary - Chart on Company Market Positioning; Exhibits8: Parent Market; Exhibits9: Data Table on - Parent Market; Exhibits10: Market characteristics analysis; Exhibits11: Value Chain Analysis; Exhibits12: Offerings of companies included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on US: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on US: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on Genomics Market in US 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Solution Segment 2018 - 2022 ($ million); Exhibits22: Five forces analysis - Comparison between 2023 and 2028; Exhibits23: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits28: Chart on Market condition - Five forces 2023 and 2028; Exhibits29: Chart on Application - Market share 2023-2028 (%); Exhibits30: Data Table on Application - Market share 2023-2028 (%); Exhibits31: Chart on Comparison by Application; Exhibits32: Data Table on Comparison by Application; Exhibits33: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits34: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits35: Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits36: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits37: Chart on Drug discovery - Market size and forecast 2023-2028 ($ million); Exhibits38: Data Table on Drug discovery - Market size and forecast 2023-2028 ($ million); Exhibits39: Chart on Drug discovery - Year-over-year growth 2023-2028 (%); Exhibits40: Data Table on Drug discovery - Year-over-year growth 2023-2028 (%); Exhibits41: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits42: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits43: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits44: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits45: Market opportunity by Application ($ million); Exhibits46: Data Table on Market opportunity by Application ($ million); Exhibits47: Chart on End-user - Market share 2023-2028 (%); Exhibits48: Data Table on End-user - Market share 2023-2028 (%); Exhibits49: Chart on Comparison by End-user; Exhibits50: Data Table on Comparison by End-user; Exhibits51: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Exhibits52: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million); Exhibits53: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Exhibits54: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%); Exhibits55: Chart on Academics and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits56: Data Table on Academics and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits57: Chart on Academics and research institutes - Year-over-year growth 2023-2028 (%); Exhibits58: Data Table on Academics and research institutes - Year-over-year growth 2023-2028 (%); Exhibits59: Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits60: Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits61: Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits62: Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits63: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits65: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits67: Market opportunity by End-user ($ million); Exhibits68: Data Table on Market opportunity by End-user ($ million); Exhibits69: Chart on Solution - Market share 2023-2028 (%); Exhibits70: Data Table on Solution - Market share 2023-2028 (%); Exhibits71: Chart on Comparison by Solution; Exhibits72: Data Table on Comparison by Solution; Exhibits73: Chart on Products - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Products - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Products - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Products - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Services - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Services - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Services - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Services - Year-over-year growth 2023-2028 (%); Exhibits81: Market opportunity by Solution ($ million); Exhibits82: Data Table on Market opportunity by Solution ($ million); Exhibits83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits84: Impact of drivers and challenges in 2023 and 2028; Exhibits85: Overview on criticality of inputs and factors of differentiation; Exhibits86: Overview on factors of disruption; Exhibits87: Impact of key risks on business; Exhibits88: Companies covered; Exhibits89: Matrix on companies position and classification; Exhibits90: Agilent Technologies Inc. - Overview; Exhibits91: Agilent Technologies Inc. - Business segments; Exhibits92: Agilent Technologies Inc. - Key news; Exhibits93: Agilent Technologies Inc. - Key offerings; Exhibits94: Agilent Technologies Inc. - Segment focus; Exhibits95: BGI Genomics Co. Ltd. - Overview; Exhibits96: BGI Genomics Co. Ltd. - Product / Service; Exhibits97: BGI Genomics Co. Ltd. - Key offerings; Exhibits98: Bio Rad Laboratories Inc. - Overview; Exhibits99: Bio Rad Laboratories Inc. - Business segments; Exhibits100: Bio Rad Laboratories Inc. - Key news; Exhibits101: Bio Rad Laboratories Inc. - Key offerings; Exhibits102: Bio Rad Laboratories Inc. - Segment focus; Exhibits103: Color Health Inc. - Overview; Exhibits104: Color Health Inc. - Product / Service; Exhibits105: Color Health Inc. - Key offerings; Exhibits106: Danaher Corp. - Overview; Exhibits107: Danaher Corp. - Business segments; Exhibits108: Danaher Corp. - Key news; Exhibits109: Danaher Corp. - Key offerings; Exhibits110: Danaher Corp. - Segment focus; Exhibits111: F. Hoffmann La Roche Ltd. - Overview; Exhibits112: F. Hoffmann La Roche Ltd. - Business segments; Exhibits113: F. Hoffmann La Roche Ltd. - Key news; Exhibits114: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits115: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits116: Illumina Inc. - Overview; Exhibits117: Illumina Inc. - Business segments; Exhibits118: Illumina Inc. - Key news; Exhibits119: Illumina Inc. - Key offerings; Exhibits120: Illumina Inc. - Segment focus; Exhibits121: LetsGetChecked - Overview; Exhibits122: LetsGetChecked - Product / Service; Exhibits123: LetsGetChecked - Key offerings; Exhibits124: Myriad Genetics Inc. - Overview; Exhibits125: Myriad Genetics Inc. - Product / Service; Exhibits126: Myriad Genetics Inc. - Key news; Exhibits127: Myriad Genetics Inc. - Key offerings; Exhibits128: Oxford Nanopore Technologies plc - Overview; Exhibits129: Oxford Nanopore Technologies plc - Product / Service; Exhibits130: Oxford Nanopore Technologies plc - Key offerings; Exhibits131: Pacific Biosciences of California Inc. - Overview; Exhibits132: Pacific Biosciences of California Inc. - Product / Service; Exhibits133: Pacific Biosciences of California Inc. - Key news; Exhibits134: Pacific Biosciences of California Inc. - Key offerings; Exhibits135: Perkin Elmer Inc. - Overview; Exhibits136: Perkin Elmer Inc. - Business segments; Exhibits137: Perkin Elmer Inc. - Key news; Exhibits138: Perkin Elmer Inc. - Key offerings; Exhibits139: Perkin Elmer Inc. - Segment focus; Exhibits140: QIAGEN N.V. - Overview; Exhibits141: QIAGEN N.V. - Product / Service; Exhibits142: QIAGEN N.V. - Key news; Exhibits143: QIAGEN N.V. - Key offerings; Exhibits144: Thermo Fisher Scientific Inc. - Overview; Exhibits145: Thermo Fisher Scientific Inc. - Business segments; Exhibits146: Thermo Fisher Scientific Inc. - Key news; Exhibits147: Thermo Fisher Scientific Inc. - Key offerings; Exhibits148: Thermo Fisher Scientific Inc. - Segment focus; Exhibits149: Twist Bioscience Corp. - Overview; Exhibits150: Twist Bioscience Corp. - Product / Service; Exhibits151: Twist Bioscience Corp. - Key offerings; Exhibits152: Inclusions checklist; Exhibits153: Exclusions checklist; Exhibits154: Currency conversion rates for US$; Exhibits155: Research methodology; Exhibits156: Information sources; Exhibits157: Data validation; Exhibits158: Validation techniques employed for market sizing; Exhibits159: Data synthesis; Exhibits160: 360 degree market analysis; Exhibits161: List of abbreviations